Authors: DIXON RM MEIRE HB EVANS DH WATT H ON N POSNER J ROLAN PE

Citation: Rm. Dixon et al., PERIPHERAL VASCULAR EFFECTS AND PHARMACOKINETICS OF THE ANTIMIGRAINE COMPOUND, ZOLMITRIPTAN, IN COMBINATION WITH ORAL ERGOTAMINE IN HEALTHY-VOLUNTEERS, Cephalalgia, 17(6), 1997, pp. 639-646

Authors: SEABER E ON N DIXON RM GIBBENS M LEAVENS WJ LIPTROT J CHITTICK G POSNER J ROLAN PE PECK RW

Citation: E. Seaber et al., THE ABSOLUTE BIOAVAILABILITY AND METABOLIC DISPOSITION OF THE NOVEL ANTIMIGRAINE COMPOUND ZOLMITRIPTAN (311C90), British journal of clinical pharmacology, 43(6), 1997, pp. 579-587

Authors: SEABER E ON N PHILLIPS S CHURCHUS R POSNER J ROLAN P

Citation: E. Seaber et al., THE TOLERABILITY AND PHARMACOKINETICS OF THE NOVEL ANTIMIGRAINE COMPOUND 311C90 IN HEALTHY MALE-VOLUNTEERS, British journal of clinical pharmacology, 41(2), 1996, pp. 141-147

Authors: SOULLAWTON J SEABER E ON N WOOTTON R ROLAN P POSNER J

Citation: J. Soullawton et al., ABSOLUTE BIOAVAILABILITY AND METABOLIC DISPOSITION OF VALACICLOVIR, THE L-VALYL ESTER OF ACYCLOVIR, FOLLOWING ORAL-ADMINISTRATION TO HUMANS, Antimicrobial agents and chemotherapy, 39(12), 1995, pp. 2759-2764